Search

everythinglearnresearchcommunity

for

Search:↓

Young women with PCOS without additional risk factors may have normal heart function.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Women with PCOS tend to be less optimistic than those without it.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.

Most women with PCOS have insulin resistance, especially those with phenotype B.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Melatonin improved mental health and metabolism in women with PCOS.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Women with PCOS have more emotional and body image issues than healthy women.

Most adult women with PCOS in Port Harcourt, Nigeria, have high levels of bad fats in their blood, especially younger women.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Women with irregular periods have a higher risk of heart disease.

Women with PCOS have a similar chance of getting pregnant using assisted reproductive treatment as those without PCOS.

Lower SHBG levels may increase the risk of PCOS.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Excessive hair growth affects the quality of life of Iranian women with PCOS the most.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.